Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Sensitivity and specificity of early screening for autism.

Surén P, Saasen-Havdahl A, Bresnahan M, Hirtz D, Hornig M, Lord C, Reichborn-Kjennerud T, Schjølberg S, Øyen AS, Magnus P, Susser E, Lipkin WI, Stoltenberg C.

BJPsych Open. 2019 May 17;5(3):e41. doi: 10.1192/bjo.2019.34.

2.

Association of Circulating Proinflammatory and Anti-inflammatory Protein Biomarkers in Extremely Preterm Born Children with Subsequent Brain Magnetic Resonance Imaging Volumes and Cognitive Function at Age 10 Years.

Kuban KCK, Jara H, O'Shea TM, Heeren T, Joseph RM, Fichorova RN, Alshamrani K, Aakil A, Beaulieu F, Horn M, Douglass LM, Frazier JA, Hirtz D, Rollins JV, Cochran D, Paneth N; ELGAN Study Investigators.

J Pediatr. 2019 Jul;210:81-90.e3. doi: 10.1016/j.jpeds.2019.03.018. Epub 2019 May 7.

PMID:
31076229
3.

Sickle Cell Disease and Stroke.

Hirtz D, Kirkham FJ.

Pediatr Neurol. 2019 Jun;95:34-41. doi: 10.1016/j.pediatrneurol.2019.02.018. Epub 2019 Feb 27. Review.

PMID:
30948147
4.

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Park EL, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J.

Epilepsy Curr. 2018 Jul-Aug;18(4):269-278. doi: 10.5698/1535-7597.18.4.269.

5.

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Park EL, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J.

Epilepsy Curr. 2018 Jul-Aug;18(4):260-268. doi: 10.5698/1535-7597.18.4.260.

6.

Among Children Born Extremely Preterm a Higher Level of Circulating Neurotrophins Is Associated with Lower Risk of Cognitive Impairment at School Age.

Kuban KCK, Heeren T, O'Shea TM, Joseph RM, Fichorova RN, Douglass L, Jara H, Frazier JA, Hirtz D, Taylor HG, Rollins JV, Paneth N; ELGAN Study Investigators.

J Pediatr. 2018 Oct;201:40-48.e4. doi: 10.1016/j.jpeds.2018.05.021. Epub 2018 Jul 18.

7.

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Llanas Park E, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J.

Neurology. 2018 Jul 10;91(2):82-90. doi: 10.1212/WNL.0000000000005756. Epub 2018 Jun 13. Erratum in: Neurology. 2018 Dec 11;91(24):1117.

PMID:
29898974
8.

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Kanner AM, Ashman E, Gloss D, Harden C, Bourgeois B, Bautista JF, Abou-Khalil B, Burakgazi-Dalkilic E, Llanas Park E, Stern J, Hirtz D, Nespeca M, Gidal B, Faught E, French J.

Neurology. 2018 Jul 10;91(2):74-81. doi: 10.1212/WNL.0000000000005755. Epub 2018 Jun 13.

PMID:
29898971
9.

A checklist for clinical trials in rare disease: obstacles and anticipatory actions-lessons learned from the FOR-DMD trial.

Crow RA, Hart KA, McDermott MP, Tawil R, Martens WB, Herr BE, McColl E, Wilkinson J, Kirschner J, King WM, Eagle M, Brown MW, Hirtz D, Lochmuller H, Straub V, Ciafaloni E, Shieh PB, Spinty S, Childs AM, Manzur AY, Morandi L, Butterfield RJ, Horrocks I, Roper H, Flanigan KM, Kuntz NL, Mah JK, Morrison L, Darras BT, von der Hagen M, Schara U, Wilichowski E, Mongini T, McDonald CM, Vita G, Barohn RJ, Finkel RS, Wicklund M, McMillan HJ Jr, Hughes I, Pegoraro E, Bryan Burnette W, Howard JF, Thangarajh M, Campbell C, Griggs RC, Bushby K, Guglieri M.

Trials. 2018 May 10;19(1):291. doi: 10.1186/s13063-018-2645-0. Review.

10.

Co-occurrence and Severity of Neurodevelopmental Burden (Cognitive Impairment, Cerebral Palsy, Autism Spectrum Disorder, and Epilepsy) at Age Ten Years in Children Born Extremely Preterm.

Hirschberger RG, Kuban KCK, O'Shea TM, Joseph RM, Heeren T, Douglass LM, Stafstrom CE, Jara H, Frazier JA, Hirtz D, Rollins JV, Paneth N; ELGAN Study Investigators.

Pediatr Neurol. 2018 Feb;79:45-52. doi: 10.1016/j.pediatrneurol.2017.11.002. Epub 2017 Nov 13.

11.

Pretreatment behavior and subsequent medication effects in childhood absence epilepsy.

Shinnar RC, Shinnar S, Cnaan A, Clark P, Dlugos D, Hirtz DG, Hu F, Liu C, Masur D, Weiss EF, Glauser TA; Childhood Absence Epilepsy Study Group.

Neurology. 2017 Oct 17;89(16):1698-1706. doi: 10.1212/WNL.0000000000004514. Epub 2017 Sep 15.

12.

Pretreatment seizure semiology in childhood absence epilepsy.

Kessler SK, Shinnar S, Cnaan A, Dlugos D, Conry J, Hirtz DG, Hu F, Liu C, Mizrahi EM, Moshé SL, Clark P, Glauser TA; Childhood Absence Epilepsy Study Group.

Neurology. 2017 Aug 15;89(7):673-679. doi: 10.1212/WNL.0000000000004226. Epub 2017 Jul 19.

13.

Cumulative Incidence of Seizures and Epilepsy in Ten-Year-Old Children Born Before 28 Weeks' Gestation.

Douglass LM, Heeren TC, Stafstrom CE, DeBassio W, Allred EN, Leviton A, O'Shea TM, Hirtz D, Rollins J, Kuban K.

Pediatr Neurol. 2017 Aug;73:13-19. doi: 10.1016/j.pediatrneurol.2017.05.009. Epub 2017 May 18.

14.

Prenatal fever and autism risk.

Hornig M, Bresnahan MA, Che X, Schultz AF, Ukaigwe JE, Eddy ML, Hirtz D, Gunnes N, Lie KK, Magnus P, Mjaaland S, Reichborn-Kjennerud T, Schjølberg S, Øyen AS, Levin B, Susser ES, Stoltenberg C, Lipkin WI.

Mol Psychiatry. 2018 Mar;23(3):759-766. doi: 10.1038/mp.2017.119. Epub 2017 Jun 13.

15.

Developing standardized corticosteroid treatment for Duchenne muscular dystrophy.

Guglieri M, Bushby K, McDermott MP, Hart KA, Tawil R, Martens WB, Herr BE, McColl E, Wilkinson J, Kirschner J, King WM, Eagle M, Brown MW, Willis T, Hirtz D, Shieh PB, Straub V, Childs AM, Ciafaloni E, Butterfield RJ, Horrocks I, Spinty S, Flanigan KM, Kuntz NL, Baranello G, Roper H, Morrison L, Mah JK, Manzur AY, McDonald CM, Schara U, von der Hagen M, Barohn RJ, Campbell C, Darras BT, Finkel RS, Vita G, Hughes I, Mongini T, Pegoraro E, Wicklund M, Wilichowski E, Bryan Burnette W, Howard JF, McMillan HJ, Thangarajh M, Griggs RC.

Contemp Clin Trials. 2017 Jul;58:34-39. doi: 10.1016/j.cct.2017.04.008. Epub 2017 Apr 24.

16.

Correction for Mahic et al., "Maternal Immunoreactivity to Herpes Simplex Virus 2 and Risk of Autism Spectrum Disorder in Male Offspring".

Mahic M, Mjaaland S, Bøvelstad HM, Gunnes N, Susser E, Bresnahan M, Øyen AS, Levin B, Che X, Hirtz D, Reichborn-Kjennerud T, Schjølberg S, Roth C, Magnus P, Stoltenberg C, Surén P, Hornig M, Lipkin WI.

mSphere. 2017 Apr 12;2(2). pii: e00154-17. doi: 10.1128/mSphere.00154-17. eCollection 2017 Mar-Apr.

17.

Maternal Immunoreactivity to Herpes Simplex Virus 2 and Risk of Autism Spectrum Disorder in Male Offspring.

Mahic M, Mjaaland S, Bøvelstad HM, Gunnes N, Susser E, Bresnahan M, Øyen AS, Levin B, Che X, Hirtz D, Reichborn-Kjennerud T, Schjølberg S, Roth C, Magnus P, Stoltenberg C, Surén P, Hornig M, Lipkin WI.

mSphere. 2017 Feb 22;2(1). pii: e00016-17. doi: 10.1128/mSphere.00016-17. eCollection 2017 Jan-Feb. Erratum in: mSphere. 2017 Apr 12;2(2):.

18.

Treatment of Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy.

Casey BM, Thom EA, Peaceman AM, Varner MW, Sorokin Y, Hirtz DG, Reddy UM, Wapner RJ, Thorp JM Jr, Saade G, Tita AT, Rouse DJ, Sibai B, Iams JD, Mercer BM, Tolosa J, Caritis SN, VanDorsten JP; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network.

N Engl J Med. 2017 Mar 2;376(9):815-825. doi: 10.1056/NEJMoa1606205.

19.

Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy.

Glauser TA, Holland K, O'Brien VP, Keddache M, Martin LJ, Clark PO, Cnaan A, Dlugos D, Hirtz DG, Shinnar S, Grabowski G; Childhood Absence Epilepsy Study Group.

Ann Neurol. 2017 Mar;81(3):444-453. doi: 10.1002/ana.24886.

20.

Targeting Environmental Neurodevelopmental Risks to Protect Children.

Hirtz D, Campbell C, Lanphear B.

Pediatrics. 2017 Feb;139(2). pii: e20162245. doi: 10.1542/peds.2016-2245. No abstract available.

21.

Second monotherapy in childhood absence epilepsy.

Cnaan A, Shinnar S, Arya R, Adamson PC, Clark PO, Dlugos D, Hirtz DG, Masur D, Glauser TA; Childhood Absence Epilepsy Study Group.

Neurology. 2017 Jan 10;88(2):182-190. doi: 10.1212/WNL.0000000000003480. Epub 2016 Dec 16.

22.

Extremely low gestational age and very low birthweight for gestational age are risk factors for autism spectrum disorder in a large cohort study of 10-year-old children born at 23-27 weeks' gestation.

Joseph RM, Korzeniewski SJ, Allred EN, O'Shea TM, Heeren T, Frazier JA, Ware J, Hirtz D, Leviton A, Kuban K; ELGAN Study Investigators.

Am J Obstet Gynecol. 2017 Mar;216(3):304.e1-304.e16. doi: 10.1016/j.ajog.2016.11.1009. Epub 2016 Nov 12.

23.

Circulating Inflammatory-Associated Proteins in the First Month of Life and Cognitive Impairment at Age 10 Years in Children Born Extremely Preterm.

Kuban KC, Joseph RM, O'Shea TM, Heeren T, Fichorova RN, Douglass L, Jara H, Frazier JA, Hirtz D, Rollins JV, Paneth N; Extremely Low Gestational Age Newborn (ELGAN) Study Investigators.

J Pediatr. 2017 Jan;180:116-123.e1. doi: 10.1016/j.jpeds.2016.09.054. Epub 2016 Oct 24.

24.

Cerebellar Hemorrhage in the Premature Infant-Time for a Balanced Approach.

Hirtz D, Ment LR.

J Pediatr. 2016 Nov;178:9-10. doi: 10.1016/j.jpeds.2016.07.036. Epub 2016 Aug 12. No abstract available.

PMID:
27526623
25.

Report of a workshop on research gaps in the treatment of cerebral palsy.

Lungu C, Hirtz D, Damiano D, Gross P, Mink JW.

Neurology. 2016 Sep 20;87(12):1293-8. doi: 10.1212/WNL.0000000000003116. Epub 2016 Aug 24.

26.

Project TENDR: Targeting Environmental Neuro-Developmental Risks The TENDR Consensus Statement.

Bennett D, Bellinger DC, Birnbaum LS, Bradman A, Chen A, Cory-Slechta DA, Engel SM, Fallin MD, Halladay A, Hauser R, Hertz-Picciotto I, Kwiatkowski CF, Lanphear BP, Marquez E, Marty M, McPartland J, Newschaffer CJ, Payne-Sturges D, Patisaul HB, Perera FP, Ritz B, Sass J, Schantz SL, Webster TF, Whyatt RM, Woodruff TJ, Zoeller RT, Anderko L, Campbell C, Conry JA, DeNicola N, Gould RM, Hirtz D, Huffling K, Landrigan PJ, Lavin A, Miller M, Mitchell MA, Rubin L, Schettler T, Tran HL, Acosta A, Brody C, Miller E, Miller P, Swanson M, Witherspoon NO; American College of Obstetricians and Gynecologists (ACOG); Child Neurology Society; Endocrine Society; International Neurotoxicology Association; International Society for Children’s Health and the Environment; International Society for Environmental Epidemiology; National Council of Asian Pacific Islander Physicians; National Hispanic Medical Association; National Medical Association.

Environ Health Perspect. 2016 Jul 1;124(7):A118-22. doi: 10.1289/EHP358. No abstract available.

28.

Prevalence and associated features of autism spectrum disorder in extremely low gestational age newborns at age 10 years.

Joseph RM, O'Shea TM, Allred EN, Heeren T, Hirtz D, Paneth N, Leviton A, Kuban KC.

Autism Res. 2017 Feb;10(2):224-232. doi: 10.1002/aur.1644. Epub 2016 May 25.

29.

What we learned about the role of antenatal magnesium sulfate for the prevention of cerebral palsy.

Rouse DJ, Hirtz D; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

Semin Perinatol. 2016 Aug;40(5):303-6. doi: 10.1053/j.semperi.2016.03.007. Epub 2016 Apr 23. Review.

30.

Neurocognitive and Academic Outcomes at Age 10 Years of Extremely Preterm Newborns.

Joseph RM, O'Shea TM, Allred EN, Heeren T, Hirtz D, Jara H, Leviton A, Kuban KC; ELGAN Study Investigators.

Pediatrics. 2016 Apr;137(4). pii: e20154343. doi: 10.1542/peds.2015-4343. Epub 2016 Mar 22.

31.

Girls and Boys Born before 28 Weeks Gestation: Risks of Cognitive, Behavioral, and Neurologic Outcomes at Age 10 Years.

Kuban KC, Joseph RM, O'Shea TM, Allred EN, Heeren T, Douglass L, Stafstrom CE, Jara H, Frazier JA, Hirtz D, Leviton A; Extremely Low Gestational Age Newborn (ELGAN) Study Investigators.

J Pediatr. 2016 Jun;173:69-75.e1. doi: 10.1016/j.jpeds.2016.02.048. Epub 2016 Mar 19.

32.

Efficacy of Low-Dose Buspirone for Restricted and Repetitive Behavior in Young Children with Autism Spectrum Disorder: A Randomized Trial.

Chugani DC, Chugani HT, Wiznitzer M, Parikh S, Evans PA, Hansen RL, Nass R, Janisse JJ, Dixon-Thomas P, Behen M, Rothermel R, Parker JS, Kumar A, Muzik O, Edwards DJ, Hirtz D; Autism Center of Excellence Network.

J Pediatr. 2016 Mar;170:45-53.e1-4. doi: 10.1016/j.jpeds.2015.11.033. Epub 2015 Dec 30.

33.

Structure, Process, and Culture Differences of Pediatric Trauma Centers Participating in an International Comparative Effectiveness Study of Children with Severe Traumatic Brain Injury.

Larsen GY, Schober M, Fabio A, Wisniewski SR, Grant MJ, Shafi N, Bennett TD, Hirtz D, Bell MJ.

Neurocrit Care. 2016 Jun;24(3):353-60. doi: 10.1007/s12028-015-0218-6.

34.

Long-term outcomes of generalized tonic-clonic seizures in a childhood absence epilepsy trial.

Shinnar S, Cnaan A, Hu F, Clark P, Dlugos D, Hirtz DG, Masur D, Mizrahi EM, Moshé SL, Glauser TA; Childhood Absence Epilepsy Study Group.

Neurology. 2015 Sep 29;85(13):1108-14. doi: 10.1212/WNL.0000000000001971. Epub 2015 Aug 26.

35.

Antenatal Magnesium and Cerebral Palsy in Preterm Infants.

Hirtz DG, Weiner SJ, Bulas D, DiPietro M, Seibert J, Rouse DJ, Mercer BM, Varner MW, Reddy UM, Iams JD, Wapner RJ, Sorokin Y, Thorp JM Jr, Ramin SM, Malone FD, Carpenter MW, O'Sullivan MJ, Peaceman AM, Hankins GD, Dudley D, Caritis SN; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

J Pediatr. 2015 Oct;167(4):834-839.e3. doi: 10.1016/j.jpeds.2015.06.067. Epub 2015 Aug 5.

36.

Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics.

Wilmshurst JM, Gaillard WD, Vinayan KP, Tsuchida TN, Plouin P, Van Bogaert P, Carrizosa J, Elia M, Craiu D, Jovic NJ, Nordli D, Hirtz D, Wong V, Glauser T, Mizrahi EM, Cross JH.

Epilepsia. 2015 Aug;56(8):1185-97. doi: 10.1111/epi.13057. Epub 2015 Jun 30. Review.

37.

Association of maternal report of infant and toddler gastrointestinal symptoms with autism: evidence from a prospective birth cohort.

Bresnahan M, Hornig M, Schultz AF, Gunnes N, Hirtz D, Lie KK, Magnus P, Reichborn-Kjennerud T, Roth C, Schjølberg S, Stoltenberg C, Surén P, Susser E, Lipkin WI.

JAMA Psychiatry. 2015 May;72(5):466-74. doi: 10.1001/jamapsychiatry.2014.3034.

38.

The breadth and type of systemic inflammation and the risk of adverse neurological outcomes in extremely low gestation newborns.

Kuban KC, O'Shea TM, Allred EN, Fichorova RN, Heeren T, Paneth N, Hirtz D, Dammann O, Leviton A; ELGAN Study Investigators.

Pediatr Neurol. 2015 Jan;52(1):42-8. doi: 10.1016/j.pediatrneurol.2014.10.005. Epub 2014 Oct 16.

39.

Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.

DeBaun MR, Gordon M, McKinstry RC, Noetzel MJ, White DA, Sarnaik SA, Meier ER, Howard TH, Majumdar S, Inusa BP, Telfer PT, Kirby-Allen M, McCavit TL, Kamdem A, Airewele G, Woods GM, Berman B, Panepinto JA, Fuh BR, Kwiatkowski JL, King AA, Fixler JM, Rhodes MM, Thompson AA, Heiny ME, Redding-Lallinger RC, Kirkham FJ, Dixon N, Gonzalez CE, Kalinyak KA, Quinn CT, Strouse JJ, Miller JP, Lehmann H, Kraut MA, Ball WS Jr, Hirtz D, Casella JF.

N Engl J Med. 2014 Aug 21;371(8):699-710. doi: 10.1056/NEJMoa1401731.

40.

Parental obesity and risk of autism spectrum disorder.

Surén P, Gunnes N, Roth C, Bresnahan M, Hornig M, Hirtz D, Lie KK, Lipkin WI, Magnus P, Reichborn-Kjennerud T, Schjølberg S, Susser E, Oyen AS, Smith GD, Stoltenberg C.

Pediatrics. 2014 May;133(5):e1128-38. doi: 10.1542/peds.2013-3664. Epub 2014 Apr 7.

41.

Inclusion and exclusion criteria for epilepsy clinical trials-recommendations from the April 30, 2011 NINDS workshop.

Fertig E, Fureman BE, Bergey GK, Brodie MA, Hesdorffer DC, Hirtz D, Kossoff EH, LaFrance WC Jr, Versavel M, French J; National Institute of Neurological Disorders and Stroke.

Epilepsy Res. 2014 Jul;108(5):825-32. doi: 10.1016/j.eplepsyres.2014.02.011. Epub 2014 Mar 1.

42.

Systemic inflammation and cerebral palsy risk in extremely preterm infants.

Kuban KC, O'Shea TM, Allred EN, Paneth N, Hirtz D, Fichorova RN, Leviton A; ELGAN Study Investigators.

J Child Neurol. 2014 Dec;29(12):1692-8. doi: 10.1177/0883073813513335. Epub 2014 Mar 18.

43.

Identifying children with autism spectrum disorder at 18 months in a general population sample.

Stenberg N, Bresnahan M, Gunnes N, Hirtz D, Hornig M, Lie KK, Lipkin WI, Lord C, Magnus P, Reichborn-Kjennerud T, Schjølberg S, Surén P, Susser E, Svendsen BK, von Tetzchner S, Oyen AS, Stoltenberg C.

Paediatr Perinat Epidemiol. 2014 May;28(3):255-62. doi: 10.1111/ppe.12114. Epub 2014 Feb 18.

44.

Headache and migraine in children with sickle cell disease are associated with lower hemoglobin and higher pain event rates but not silent cerebral infarction.

Dowling MM, Noetzel MJ, Rodeghier MJ, Quinn CT, Hirtz DG, Ichord RN, Kwiatkowski JL, Roach ES, Kirkham FJ, Casella JF, DeBaun MR.

J Pediatr. 2014 May;164(5):1175-1180.e1. doi: 10.1016/j.jpeds.2014.01.001. Epub 2014 Feb 13.

45.

Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsy.

Masur D, Shinnar S, Cnaan A, Shinnar RC, Clark P, Wang J, Weiss EF, Hirtz DG, Glauser TA; Childhood Absence Epilepsy Study Group.

Neurology. 2013 Oct 29;81(18):1572-80. doi: 10.1212/WNL.0b013e3182a9f3ca. Epub 2013 Oct 2.

46.

NINDS epilepsy and autism spectrum disorders workshop report.

Tuchman R, Hirtz D, Mamounas LA.

Neurology. 2013 Oct 29;81(18):1630-6. doi: 10.1212/WNL.0b013e3182a9f482. Epub 2013 Oct 2. Review.

47.

Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial.

King BH, Dukes K, Donnelly CL, Sikich L, McCracken JT, Scahill L, Hollander E, Bregman JD, Anagnostou E, Robinson F, Sullivan L, Hirtz D.

JAMA Pediatr. 2013 Nov;167(11):1045-52. doi: 10.1001/jamapediatrics.2013.2698.

48.

Analysis of self-selection bias in a population-based cohort study of autism spectrum disorders.

Nilsen RM, Surén P, Gunnes N, Alsaker ER, Bresnahan M, Hirtz D, Hornig M, Lie KK, Lipkin WI, Reichborn-Kjennerud T, Roth C, Schjølberg S, Smith GD, Susser E, Vollset SE, Øyen AS, Magnus P, Stoltenberg C.

Paediatr Perinat Epidemiol. 2013 Nov;27(6):553-63.

49.

Early growth patterns in children with autism.

Surén P, Stoltenberg C, Bresnahan M, Hirtz D, Lie KK, Lipkin WI, Magnus P, Reichborn-Kjennerud T, Schjølberg S, Susser E, Oyen AS, Li L, Hornig M.

Epidemiology. 2013 Sep;24(5):660-70. doi: 10.1097/EDE.0b013e31829e1d45. Erratum in: Epidemiology. 2014 Jan;25(1):164.

50.

Pretreatment EEG in childhood absence epilepsy: associations with attention and treatment outcome.

Dlugos D, Shinnar S, Cnaan A, Hu F, Moshé S, Mizrahi E, Masur D, Sogawa Y, Le Pichon JB, Levine C, Hirtz D, Clark P, Adamson PC, Glauser T; Childhood Absence Epilepsy Study Team.

Neurology. 2013 Jul 9;81(2):150-6. doi: 10.1212/WNL.0b013e31829a3373. Epub 2013 May 29.

Supplemental Content

Support Center